SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-15-023818
Filing Date
2015-04-20
Accepted
2015-04-20 17:00:24
Documents
1
Group Members
JOSHUA LANDESNELSON OBUSWYNNEFIELD CAPITAL MANAGEMENT, LLCWYNNEFIELD CAPITAL, INC.WYNNEFIELD CAPITAL, INC. PROFIT SHARING PLANWYNNEFIELD PARTNERS SMALL CAP VALUE, L.P.WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v407124_sc13d.htm SC 13D 158011
  Complete submission text file 0001144204-15-023818.txt   159906
Mailing Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123
Business Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123 212-760-0814
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Filed by) CIK: 0001251565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Subject) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85226 | Film No.: 15781161
SIC: 2834 Pharmaceutical Preparations